Cardionomic is a company that provides cardiac treatments intended to be used for treating acute decompensated heart failure. Its cardiac treatments address the condition's root cause of reduced contractility using neuromodulation to increase contractility, thus improving cardiac output and increasing renal flow or end-organ perfusion. The company aims to help healthcare practitioners to decrease negative hormonal signaling and improve in-hospital morbidity and mortality.